Research News
View articles by month and year
-
FDA Issues Warning on Evamist Spray
The U.S. Food and Drug Administration is warning women who use Evamist that children and pets shouldn't touch the skin where the HRT is sprayed.
-
Experimental Genomic Test May Help Predict Risk of Hormone-Receptor-Positive Disease Recurrence
An experimental test may be able to help predict the risk of hormone-receptor-positive breast cancer, but it's not clear how useful the test is.
-
Research Looks for Links Between Fish Oil, Lower Risk
Research suggests a link between fish oil and a lower risk of breast cancer, but more research is needed.
-
Doctors Favor Gradually Stopping Hormone Replacement Therapy
Most family medicine, internal medicine, and obstetrician-gynecologist (ob/gyn) doctors recommend gradually stopping HRT over time instead of suddenly stopping it.
-
Oral Bisphosphonates May Reduce Risk for Postmenopausal Women
Two studies suggest that oral bisphosphonates may reduce the risk of invasive breast cancer in postmenopausal women by 30% to 40%.
-
Some Parents Who’ve Been Tested Support Abnormal Breast Cancer Gene Testing for Kids
About a third of people who were tested for abnormal breast cancer genes (BRCA1 or BRCA2), supported the same testing for their children.
-
Obesity Linked to Larger, More Aggressive Breast Cancers
New research adds to evidence linking obesity and breast cancers that are larger and more advanced at diagnosis.
-
Genetic Changes in DCIS Cells May Help Predict Invasive Breast Cancer Risk
New research suggests that certain genetic characteristics in DCIS cells may help predict the risk of future invasive breast cancer.
-
Breast Cancer Risk Factors Seemingly Less Influential in Hispanic Women
A new study suggests that links between known breast cancer risk factors and breast cancer diagnosis isn't as strong in Hispanic women compared to non-Hispanic white women.
-
Overactive HOTAIR Gene Makes Breast Cancer More Likely to Metastasize
New research has found that breast cancers with an overactive HOTAIR (HOX antisense intergenic RNA) gene are more likely to spread to parts of the body away from the breast (metastasize).
